Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CorMedix Inc.

    NASDAQ: CRMD · Real-Time Price · USD
    12.46
    -2.50 (-16.71%)
    At close: Jun 27, 2025, 3:59 PM
    12.56
    0.84%
    After-hours: Jun 27, 2025, 05:58 PM EDT

    CorMedix Statistics

    Share Statistics

    CorMedix has 67.82M shares outstanding. The number of shares has increased by 10.4% in one year.

    Shares Outstanding

    n/a
    		 67.82M

    Shares Change (YoY)

    n/a
    		 10.4%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 39.02%

    Shares Floating

    n/a
    		 65.96M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,349

    FTD / Avg. Volume

    n/a
    		 0.07%

    Short Selling Information

    The latest short interest is 8.53M, so 12.58% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.53M

    Short % of Shares Out

    n/a
    		 12.58%

    Short % of Float

    n/a
    		 12.73%

    Short Ratio (days to cover)

    n/a
    		 7.44

    Valuation Ratios

    The PE ratio is -26.6 and the forward PE ratio is 10.78. CorMedix's PEG ratio is 0.4.

    PE Ratio

    n/a
    		 -26.6

    Forward PE

    n/a
    		 10.78

    PS Ratio

    n/a
    		 10.97

    Forward PS

    n/a
    		 3.1

    PB Ratio

    n/a
    		 0.01

    P/FCF Ratio

    n/a
    		 -9.4

    PEG Ratio

    n/a
    		 0.4
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for CorMedix.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    Current Ratio

    n/a
    		 0

    Quick Ratio

    n/a
    		 0

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -614.1

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $679,252.66

    Profits Per Employee

    n/a
    		 $-280,156.56

    Employee Count

    n/a
    		 64

    Asset Turnover

    n/a
    		 0.37

    Inventory Turnover

    n/a
    		 0.42

    Taxes

    Income Tax

    n/a
    		 -1.39M

    Effective Tax Rate

    n/a
    		 7.22%

    Stock Price Statistics

    The stock price has increased by 246.19% in the last 52 weeks. The beta is 1.61, so CorMedix's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.61

    52-Week Price Change

    n/a
    		 246.19%

    50-Day Moving Average

    n/a
    		 11.89

    200-Day Moving Average

    n/a
    		 10.18

    Relative Strength Index (RSI)

    n/a
    		 60.13

    Average Volume (20 Days)

    n/a
    		 1,875,040

    Income Statement

    In the last 12 months, CorMedix had revenue of 43.47M and earned -17.93M in profits. Earnings per share was -0.3.

    Revenue

    n/a
    		 43.47M

    Gross Profit

    n/a
    		 40.28M

    Operating Income

    n/a
    		 -22.36M

    Net Income

    n/a
    		 -17.93M

    EBITDA

    n/a
    		 -18.83M

    EBIT

    n/a
    		 -19.29M

    Earnings Per Share (EPS)

    n/a
    		 -0.3
    Full Income Statement

    Balance Sheet

    The company has 40.65M in cash and 517.01K in debt, giving a net cash position of 40.13M.

    Cash & Cash Equivalents

    n/a
    		 40.65M

    Total Debt

    n/a
    		 517.01K

    Net Cash

    n/a
    		 40.13M

    Retained Earnings

    n/a
    		 -339.63B

    Total Assets

    n/a
    		 149.58M

    Working Capital

    n/a
    		 110.47M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -50.61M and capital expenditures -115.73K, giving a free cash flow of -50.73M.

    Operating Cash Flow

    n/a
    		 -50.61M

    Capital Expenditures

    n/a
    		 -115.73K

    Free Cash Flow

    n/a
    		 -50.73M

    FCF Per Share

    n/a
    		 -0.86
    Full Cash Flow Statement

    Margins

    Gross margin is 92.66%, with operating and profit margins of -51.43% and -41.24%.

    Gross Margin

    n/a
    		 92.66%

    Operating Margin

    n/a
    		 -51.43%

    Pretax Margin

    n/a
    		 -44.45%

    Profit Margin

    n/a
    		 -41.24%

    EBITDA Margin

    n/a
    		 -43.32%

    EBIT Margin

    n/a
    		 -51.43%

    FCF Margin

    n/a
    		 -116.7%

    Dividends & Yields

    CRMD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CRMD is $17, which is 13.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $17

    Price Target Difference

    n/a
    		 13.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 26, 2019. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Mar 26, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 13.42

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist